Survey of Retina Specialists' Attitudes and Practice Patterns of Screening and Management of Endophthalmitis.

Purpose: To understand retina specialists' attitudes and practice patterns for screening for and managing endophthalmitis and any impact of the COVID-19 pandemic on these practice patterns.

Methods: A survey was developed on Survey Monkey and distributed to ASRS regular members via email in April 2021.

Results: The survey had 231 respondents, of whom 169 (73%) performed inpatient consultations.

Long-Term Follow-Up of Retinal Detachment Repair in Patients With Stickler Syndrome.

Background And Objective: To report the long-term anatomic and visual outcomes of patients with Stickler syndrome undergoing retinal detachment (RD) surgery.

Patients And Methods: Retrospective, interventional, consecutive case series of patients with Stickler syndrome undergoing RD repair from 1999 to 2017 at the Long Island Vitreoretinal Consultants, New York. Retinal attachment status and visual acuity (VA) at 1-year and last follow-up were assessed.

Incidence and Risk of Scleral-Fixated Akreos (AO60) Lens Opacification: A Case Series.

Purpose: Postoperative hydrophilic intraocular lens opacification can lead to decreased vision and may require intraocular lens exchange. This study aims to identify the incidence of scleral-fixated Akreos AO60's (Bausch + Lomb) lens opacification and risk factors for this phenomenon.

Methods: This is a retrospective case series of all patients who underwent scleral-fixated Akreos AO60 lens at our institution between January 1, 2015 and December 31, 2019.

Early initial clinical experience with intravitreal aflibercept for wet age-related macular degeneration.

Background: Age-related macular degeneration (AMD) is a degenerative process that leads to severe vision loss. Wet AMD is defined by choroidal neovascularisation, leading to the accumulation of subretinal fluid (SRF), macular oedema (ME), and pigment epithelium detachments (PED). Purpose To evaluate the initial clinical experience of conversion from bevacizumab or ranibizumab to aflibercept in wet AMD patients.

Pars plana vitrectomy in the management of patients diagnosed with endophthalmitis following intravitreal anti-vascular endothelial growth factor injection.

Purpose: To evaluate the possible benefit of pars plana vitrectomy in the treatment of patients with endophthalmitis following antivascular endothelial growth factor (VEGF) injection.

Method: The authors retrospectively reviewed the medical records of all patients in their practice with a diagnosis of endophthalmitis from January 1, 2007, through December 31, 2011. Only those with a clinical presentation consistent with endophthalmitis after intravitreal anti-VEGF injection were included.